Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benchun Miao

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Nature Medicine|October 19, 2018
Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domainsBenchun Miao, Igor Skidan, Jinsheng Yang, et al.
Nature Medicine|August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
The Journal of Allergy and Clinical Immunology|April 2, 2011
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitisBodi Zhang, Konstantinos-Dionysios Alysandratos, Asimenia Angelidou, et al.
Nature Communications|October 16, 2021
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanomaKuang Du, Shiyou Wei, Zhi Wei, et al.
The Journal of Investigative Dermatology|February 7, 2018
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in MelanomaPhilip Eliades, Brian J Abraham, Zhenyu Ji, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapyAndrew D Knight, Emily J Robitschek, Jia-Ren Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant MelanomaCharles Marusak, Varsha Thakur, Yuan Li, et al.
Journal of the National Cancer Institute|March 10, 2018
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome SequencingMykyta Artomov, Alexander J Stratigos, Ivana Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Nature Medicine|October 19, 2018
Publisher Correction: Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domainsBenchun Miao, Igor Skidan, Jinsheng Yang, et al.
Nature Medicine|August 22, 2018
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanomaNoam Auslander, Gao Zhang, Joo Sang Lee, et al.
The Journal of Allergy and Clinical Immunology|April 2, 2011
Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: relevance to atopic dermatitisBodi Zhang, Konstantinos-Dionysios Alysandratos, Asimenia Angelidou, et al.
Nature Communications|October 16, 2021
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanomaKuang Du, Shiyou Wei, Zhi Wei, et al.
The Journal of Investigative Dermatology|February 7, 2018
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in MelanomaPhilip Eliades, Brian J Abraham, Zhenyu Ji, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapyAndrew D Knight, Emily J Robitschek, Jia-Ren Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 22, 2020
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant MelanomaCharles Marusak, Varsha Thakur, Yuan Li, et al.
Journal of the National Cancer Institute|March 10, 2018
Rare Variant, Gene-Based Association Study of Hereditary Melanoma Using Whole-Exome SequencingMykyta Artomov, Alexander J Stratigos, Ivana Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
A Fatty Acid Oxidation-dependent Metabolic Shift Regulates the Adaptation of <i>BRAF</i>-mutated Melanoma to MAPK InhibitorsAndrea Aloia, Daniela Müllhaupt, Christophe D Chabbert, et al.
Pageof 4